000158:SSEShijiazhuang ChangShan BeiMing Technology Co.,Ltd Analysis
Data as of 2026-03-12 - not real-time
CN¥20.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading around its short‑term moving averages with a bullish MACD histogram, yet it remains below the long‑term 200‑day average, signaling a broader bearish bias. Support sits just under the current price while resistance is a few points higher, and the 30‑day volatility is elevated, though trading volume is on the rise.
Fundamental outlook: Revenue has contracted sharply and margins are negative, while the balance sheet is strained by a debt load that dwarfs equity. Forward earnings are modestly positive, but valuation multiples are high, with a forward price‑to‑earnings ratio in the forties and a price‑to‑book well above six, and the company does not pay a dividend. The combination of weak profitability, heavy leverage, and premium pricing makes the stock appear overvalued despite some short‑term technical optimism.
Fundamental outlook: Revenue has contracted sharply and margins are negative, while the balance sheet is strained by a debt load that dwarfs equity. Forward earnings are modestly positive, but valuation multiples are high, with a forward price‑to‑earnings ratio in the forties and a price‑to‑book well above six, and the company does not pay a dividend. The combination of weak profitability, heavy leverage, and premium pricing makes the stock appear overvalued despite some short‑term technical optimism.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below long‑term moving average indicating bearish bias
- High debt relative to equity
- Elevated valuation multiples
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD suggesting possible short‑term upside
- Forward earnings turning positive
- Continued leverage concerns
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative margins and cash flow deficits
- Heavy debt burden limiting financial flexibility
- Overvaluation relative to earnings prospects
Key Metrics & Analysis
Financial Health
Revenue Growth-33.20%
Profit Margin-5.00%
P/E Ratio42.1
ROE-8.38%
ROA-1.41%
Debt/Equity133.14
P/B Ratio6.3
Op. Cash FlowCN¥-493683360
Free Cash FlowCN¥-1776946688
Technical Analysis
TrendBearish
RSI50.2
SupportCN¥19.65
ResistanceCN¥22.00
MA 20CN¥20.46
MA 50CN¥20.65
MA 200CN¥22.44
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.03
Volatility25.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.